Maen Abdelrahim
Impact in
- Cancer Research top 2%
- Toxicology top 1%
Papers in
- Hepatology 27
- Hepatocellular Carcinoma Treatment and Prognosis 21
-
- Cancer Genomics and Diagnostics 26
- Co-authors
- Stephen SafeIsmael SamudioRoger SmithAla AbudayyehRobert C. BurghardtRiyaz BashaSudhakar ChintharlapalliCheryl H. Baker
- Journals
- Journal of Clinical Oncology (16 papers)Cancers (13 papers)Cancer Research (11 papers)Annals of Oncology (10 papers)Molecular Cancer Therapeutics (9 papers)
- Partner nations
- United StatesSouth KoreaJordan
In The Last Decade
Maen Abdelrahim
152 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 124
- Cancer Research 1.0k
- Toxicology 161
- Oncology 1.3k
- Molecular Biology 2.7k
- Cellular and Molecular Neuroscience 572
Countries citing papers authored by Maen Abdelrahim
This map shows the geographic impact of Maen Abdelrahim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maen Abdelrahim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maen Abdelrahim more than expected).
Fields of papers citing papers by Maen Abdelrahim
This network shows the impact of papers produced by Maen Abdelrahim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maen Abdelrahim. The network helps show where Maen Abdelrahim may publish in the future.
Co-authors
The 25 scholars most cited alongside Maen Abdelrahim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 41 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 0 | |
| 8 | 2022 | 0 | |
| 9 | 2022 | 15 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 5 | |
| 13 | 2010 | 132 | |
| 14 | 2010 | 39 | |
| 15 | 2009 | 24 | |
| 16 | 2009 | 50 | |
| 17 | Biomarkers clinical relevance in cancer: Emphasis on breast cancer and prostate cancer | 2009 | 1 |
| 18 | 2008 | 15 | |
| 19 | Selective radioprotection of normal tissues by new cerium oxide nanoparticles | 2007 | 1 |
| 20 | 2003 | 81 |
About Maen Abdelrahim
Maen Abdelrahim is a scholar working on Hepatology, Cancer Research, Transplantation, Oncology and Physiology, having authored 157 papers that have together received 5.2k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (26 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Pancreatic and Hepatic Oncology Research (20 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Cancer Immunotherapy and Biomarkers (15 papers), Nuclear Receptors and Signaling (13 papers), Viral-associated cancers and disorders (12 papers) and Estrogen and related hormone effects (10 papers). The work is most often cited by research in Cancer Research (1.0k citations), Toxicology (161 citations), Oncology (1.3k citations), Molecular Biology (2.7k citations) and Cellular and Molecular Neuroscience (572 citations). Maen Abdelrahim has collaborated with scholars based in United States, South Korea and Jordan. Frequent co-authors include Stephen Safe, Ismael Samudio, Roger Smith, Ala Abudayyeh, Robert C. Burghardt, Riyaz Basha, Sudhakar Chintharlapalli, Cheryl H. Baker, Shengxi Liu and James L. Abbruzzese. Their work appears in journals such as Journal of Clinical Oncology, Cancers, Cancer Research, Annals of Oncology and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.